The Latest Articles from Streetwise Reports


Clean Tech Co. Might Be 'Intrinsically Strong'

Contributed Opinion
  ()
Expert Clive Maund reviews Ecolomondo Corp.'s 6-month and 2-year charts to show you why he believes this stock may be strong no matter the market.
Tags:  Technology

Interim Results From Phase 2b Trial Are 'Encouraging'

Research Report
  ()
Data show the biotech's compound had a positive effect on several noninvasive measures, noted a ROTH Capital Partners report.

Silver Explorer 'Could Be Sitting on Three-Four Million Ounces'

Contributed Opinion
  ()
After speaking with the president and CEO of Arizona Silver Exploration Inc., editor and publisher of The National Investor, Chris Temple, shares why he believes its Philadelphia Project is compelling.
Tags:  Silver

Expert Says Lithium Co. 'An Immediate Speculative Buy'

Contributed Opinion
  ()
Expert Clive Maund takes a look at the 6-month and 2-year charts for Spey Resources Corp., following the completion of a large base pattern, to tell you whether he believes it is a Buy.

Biopharma Asks for Emergent Use in US of New COVID Drug

Research Report
  ()
The requested approval is specifically for critically ill patients, a population for which the U.S. Food and Drug Administration granted the therapeutic fast track status, noted an H.C. Wainwright & Co. report.

Co. Builds Copper Gold Resource at Asset Near Large Miner

Research Report
  ()
This mining firm with a robust project portfolio is exploring its newly acquired asset in Chile's Atacama region, from which results are expected soon, noted a Fundamental Research Corp. report.

Counter Drone Tech Firm Differs From Rest of Market

Research Report
  ()
This company warrants a favorable investment thesis and Buy recommendation based on many factors, noted a Bell Potter report.
Tags:  Technology

Opportunity for Investors Found in Psychedelics Space

Research Report
  ()
Treatment of alcohol use disorder with psychedelics plus therapy is effective, according to existing data, and the potential global market is large, noted an H.C. Wainwright & Co. report.
Tags:  Psychedelics

The Perfect Storm for Oil and Natural Gas

Contributed Opinion
  ()
Numerous positive influences on oil and gas prices are looking to converge this winter in North America and Europe. Expert Ron Struthers believes oil and gas stocks have been oversold and offer very good value, and he highlights two he thinks are worth your attention.

Junior Sells Lithium Projects to Focus on James Bay Gold

  ()
Quebec Precious Metals Corp. is selling all of its non-core assets so it can focus on its flagship Sakami gold project in the James Bay territory of Quebec.

Six Charts You Need To See Showing the Coming Bear Market

Contributed Opinion
  ()
Expert Michael Ballanger takes a look at a few charts to tell you how he believes the US dollar is doing and where he thinks the market may be heading.

US Biotech Firm Keeps Growing Revenue

Research Report
  ()
Revenue last quarter was strong, and management expects to increase revenue 20% this fiscal year, noted a ROTH Capital Partners report.

Green Tech Co. Uplisted to OTCQB Venture Market

  ()
Bioleaching company BacTech Environmental Corp. has begun trading on the OTCQB Venture Market as it gets ready to open a plant in Ecuador and has opened a pilot facility in Ontario.

New Assays Highlight High Copper Potential

  ()
Norseman Silver has just announced more high-grade assays of rock chip samples at its project in Argentina.

Sampling at Argentina Project Reveals Elevated Copper/Gold Values

Contributed Opinion
  ()
Michael Ballanger explains why he believes sample assays provide evidence "indicating the potential for world-class scale and value."

Co.'s Clinical Program in HPV+ Cancers Gives It a Buy Rating

Research Report
  ()
To fund continued development of its lead immunotherapy candidate, the U.S.-based biopharma recently completed a $35 million debt financing agreement, noted an H.C. Wainwright & Co. report.

Gold Co. 'Looking Like a Good Value'

Contributed Opinion
  ()
With good news shown on Tuesday, Strikepoint Gold Inc. has piqued expert Clive Maund's interest. Today he reviews the gold company's 3-year and 6-month charts to tell you where he believes the stock is headed.
Tags:  Gold

Analyst Says Buy Before Biotech Co.'s Clinical Trials

Research Report
  ()
Argenx SE has "several upcoming catalysts," noted a Wedbush report.

Showing Results: 1 to 25 of 529 Next

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe